Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
United Immunity Logo
United Immunity Growth Score
93
CB Rank
28267
Heat Score
87
United Immunity is a research firm that specializes in development, and supply of pharmaceuticals, mainly for cancer immunotherapy.
Founded
obfuscation
PrivateDebt Financing Tokyo, Tokyo, Japan11-50 unitedimmunity.co.jp/eng
Health Care
Nursing and Residential Care
Nutrition
Overview

United Immunity
Total Funding
obfuscation
Growth Score
93
Heat Score
87

Total Funding
obfuscation
obfuscation
Debt Financing raised
obfuscation
Growth Score93
9 pts
in past quarter
Heat Score 87
20 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About United Immunity

CB Rank
28267
United Immunity is a research firm that specializes in development, and supply of pharmaceuticals, mainly for cancer immunotherapy.
Founded
obfuscation
PrivateDebt Financing Tokyo, Tokyo, Japan11-50 unitedimmunity.co.jp/eng
Health Care
Nursing and Residential Care
Nutrition

Funding Rounds

Debt Financing
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Series B
OBF
in
obfuscation

Key People

  • Takatoshi Soga Logo
    Takatoshi Soga: Senior Vice President
    Past Role: Astellas Venture Management, Associate Investment Director
  • Photo of Naozumi Harada
    Naozumi Harada: Chairman
    Past Role: United Immunity, Founder, Representative Director , Chief Executive Officer & Chief Technology Officer

Details

Legal Name United Immunity, Co., Ltd.
Operating Status Active
Company Type For Profit
Founders  Naozumi Harada
About the Company
United Immunity is a research, development, manufacture and sale of pharmaceuticals, mainly for cancer immunotherapy.
Phone Number +81-059-231-5484
Contact Email info@unitedimmunity.co.jp
Predictions & Insights

Growth Insight

See this Growth Insight
United Immunity is
Lorem
 to be growing
Top Contributing Factors
Merger or Acquisition

Growth Prediction

See this Growth Prediction

Products & Services

UI-102
An intravenous injection containing TLR7/8 agonists in pullulan nanoparticles targeting tumor-associated macrophages in solid tumors to convert immune-resistant tumors into immune-sensitive ones.
In vivo CAR Macrophage (CAR-M) Technology
A method delivering mRNA encoding chimeric antigen receptors directly to tumor-associated macrophages in vivo to produce CAR-M cells within tumors, avoiding ex vivo cell manufacturing.

Research & Development

United Immunity is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing
obfuscation
Debt Financing - United Immunity Logo
Debt Financing - United Immunity
1
obfuscation
Aozora Corporate InvestmentDebt Financing

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3

Employee Profiles

News

News and Press

News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 1, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 26, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 16, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

62
-85.78%
 in past month

Active Website Tech Count

24United Immunity is actively using 24 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

7The intellectual property of United Immunity includes 6 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, United Immunity has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is United Immunity's headquarters? United Immunity is located in Tokyo, Tokyo, Japan.Who invested in United Immunity? United Immunity has 8 investors including Aozora Corporate Investment and  Saisei Ventures.When was the last funding round for United Immunity? United Immunity closed its last funding round on
obfuscation
from a Debt Financing round.Who are United Immunity's competitors? Alternatives and possible competitors to United Immunity may include Calidi Biotherapeutics, Canton Strategic Holdings, and  3T Biosciences.How much funding has United Immunity raised to date? United Immunity has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|